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Abstract
Background: The concomitant presence of idiopathic membranous nephropathy and IgA nephropathy is rare.
Here, we report 9 cases of phospholipase-A2-receptor (PLA2R) positive idiopathic membranous nephritis combined
with IgA nephropathy, while reviewing publications regarding the pathological characteristics of this
glomerolonephritis complication.
Case presentation: Nine cases of renal biopsy tissues were retrospectively reviewed, including the clinicopathological
features, the results of the immunofluorescence assays, and the electron microscopic examination. The patients mainly
presented proteinuria and microscopic hematuria, and the serum anti-PLA2R was detected as positive in all of
the patients. Histologically, a wide thickening of the glomerular basement membrane was observed in each of
the 9 cases. Additionally, there existed mild hyperplasia in the mesangial cell and the matrix of the mesangial
area. Immunofluorescence assays showed prominent glomerular granular staining on the glomerular capillary
loops for IgG (++/+++), IgG4 (++/++++), and PLA2R (+/++). In addition, moderate IgA positive stains were
focally or sparsely limited to the mesangial areas. Electron microscopy revealed subepithelial and mesangial
electron-dense deposits.
Conclusions: The results from the case analyses indicated that idiopathic membranous nephropathy combined
with IgA nephropathy possess the clinicopathological features found in both components. It is suggested that
serum anti-PLA2R and tissue PLA2R are important biomarkers that can assist in the diagnosis of idiopathic
membranous nephropathy associated with IgA nephropathy.
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Background
Membranous nephropathy (MN) and IgA nephropathy
(IgAN) are two distinct glomerular diseases. The most
common cause of nephrotic syndrome in adults can be
attributed to MN, in which approximately 70 % of this
disease can be categorized as idiopathic MN (also re-
ferred to as primary MN). In Chinese as well as other
Asian populations, IgAN has become a major patho-
logical type of glomerular disease. Furthermore, it was
estimated that IgAN accounts for 45.2 to 58.2 % of
primary glomerular diseases in China [1–3]. Recently,
an increasing number of reports have emerged in
regards to IgAN combined with other renal diseases
[1, 4]. However, studies involving the concomitant
presence of idiopathic MN and IgAN are rare. The
few reports available from studies conducted around
the world rely heavily on immunofluorescence and
electron microscopic examination to identify patients
with combined idiopathic MN and IgAN. These data
showed subepithelial and mesangial electron-dense
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deposition (EDD) in which the immunofluorescence
analysis conducted on the patient samples was posi-
tive for both IgG and IgA [5–10]. However, it may
bring some confusion in diagnosing these complica-
tions by immunofluorescence and electron micro-
scopic examination, because some secondary MN
also showed mesangial EDD in additional to sube-
pithelial deposition, while the IgAN sometime have
minimal subepithelial EDD with mesangial massive
deposition.
Recently, serum anti-phospholipase-A2-receptor (PLA2R)
antibodies were found to be the main serum auto-
antibodies presented in idiopathic MN patients.
Furthermore, previous reports have demonstrated that
M-type PLA2R is a specific marker for idiopathic MN
[11, 12]. It has been shown that PLA2R is hardly de-
tected in secondary MN and other glomerular diseases
[13, 14]. Therefore, the test of anti-PLA2R as a sensi-
tive biomarker may provide a novel diagnostic tool
for idiopathic MN, and for the differentiation of sec-
ondary MN [11, 15, 16]. This biomarker also provides
a more definitive evidence for detecting idiopathic
MN combined with IgAN in patients. In this article,
we report 9 cases of PLA2R-positive idiopathic MN
combined with IgAN, in addition to a review that dis-




Between January 2013 and December 2015, 9 cases of
patients with MN combined with IgAN were selected
from the nephrosis laboratory of the Department of
Pathology, School of Basic Medical Sciences, Fudan
University, Shanghai, China and The First Affiliated
Hospital of Zhengzhou University, Zhengzhou, China.
Data collection
These cases are comprised of patients whose renal
biopsies showed glomerular predominant IgG and
PLA2R deposits with more or less mesangial IgA de-
position, excluding the cases of differentiating renal
diseases such as lupus nephritis, HBV associated
nephritis and antineutrophil cytoplasmic autoantibody
(ANCA)-associated crescentic glomerular nephritis
(GN) with mesangial IgA deposits. The medical re-
cords of the patients were reviewed for age, gender,
type and degree of hematuria, urinary protein excre-
tion (g/24 h), and serum creatinine at the time of
biopsy.
Biopsy evaluation
Histological slides from each biopsy were stained with
hematoxylin-eosin, periodic acid-Schiff, silver methenamine,
and masson’s trichrome. In addition, immunofluorescent
staining of immunoglobulins, complement, and PLA2R
were conducted. These stained samples as well as all of
the transmission electron micrographs taken at the
time of initial biopsy evaluation were reviewed by two
renal pathologists (Dr. Wu and Dr. Zhang).
Case presentation
The clinical and serologic features of the 9 patients, 4 fe-
males and 5males, were summarized in Table 1. The
mean age was 38.3 ± 7.4 years (range 25–48 years). The
patients had no history of renal disease and bacterial in-
fection prior to the occurrence of renal complications.
The patients had nephrotic syndrome and the mean pro-
teinuria level was 4.82 ± 3.33 g/24 h (range 1.79–
11.76 g/24 h). 7 of the 9 patients had microscopic
hematuria, whereas all patients had no gross hematuria.
The mean serum creatinine at the time of biopsy was
68.67 ± 17.55 μmol/L (range 49–93 μmol/L). All patients
had increased serum PLA2R antibody prominently with
a mean level of 57.39 ± 47.89 RU/mL (range 24.6–
177.1RU/mL), while the serum IgA and complement C3
were closely distributed within the normal range in these
9 patients. 8 of the 9 cases had no hypertension history,
and only case 2 had hypertension for more than 10 years
(92–100/136–145 mmHg controlled by extended release
nifedipine tablets). The ANA,ANCA and HBV markers
detected at the time of biopsy were negative for each of
the 9 cases.
Table 2 lists the summary of the histopathological
features of the renal biopsies conducted within each of
the 9 cases. The biopsies showed a predominantly
diffuse thickening of the basement membrane of glom-
erular capillary walls. Mildly mesangial hyperplasia was
observed within 4–5 mesangial cells as well as a small
portion of the matrix in all 9 cases. Moreover, focal
glomerular tuft necrosis or crescents were absent, while
mild chronic interstitial inflammation was present in
the patient samples.
In the immunofluorescence staining, each of the
cases showed prominent glomerular granular staining
on glomerular capillary loops for IgG (++/+++), IgG4
(++/++++), and PLA2R (+/++); C3 (+/+++) also dis-
played granular staining on glomerular capillary loops.
IgA (+/++) positive staining were focally or sparsely
limited to the mesangial areas (Fig. 1a–e).
For the electron microscopy, granular EDD were
present in the subepithelium in 9 patients, in addition to
irregular thickening of the glomerular basement mem-
brane and segmental spikes. The extensive fusion of epi-
thelial foot processes was also observed. Mild, focal
proliferation of mesangial cells and the matrix were
noted (Fig. 1f ).
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Table 2 Summary of the histopathological features of renal biopsies of the 9 patients
Ca.1 Ca.2 Ca.3 Ca.4 Ca.5 Ca.6 Ca.7 Ca.8 Ca.9
LM
%globally sclerotic glomeruli 0/30 1/23 0/18 0/33 0/24 1/18 1/38 0/20 1/31
%segmentally sclerotic glomeruli 0/30 0/23 0/18 0/33 0/24 0/18 1/38 0/20 1/31
Mesangial cell proliferation + + + + + + + - +
Mesangial matrix hyperplasia + + + + + + + + +
Thickening of the capillary walls ++ + ++ ++ ++ ++ ++ ++ ++
Interstitial inflammatory + + + + ± - + - -
Focal tubular atrophy + + + + - - - - +
IF
IgG +++ ++ +++ +++ +++ ++ ++ ++ +++
IgA ++(f) + ++ +(f) ++ ++ ++ ++ ++
IgG1 +/++ ± ++ - ++ + - + -
IgG2 ± + - - ± - ± ± +
IgG3 ± +/++ - + + - ± ± -
IgG4 ++ ++ ++++ ++ +++ ++ ++ ++ ++
PLA2R + + + ++ +/++ + + + +
C3 +/++ + ++ +/++ +++ + +/++ + ++
EM
Subepithelium EDD ++ ++ ++ ++ ++ ++ +++ ++ ++
Mesangial area EDD ++ + + + + + ++ + +
Extensive processes effacement ++ ++ ++ ++ +/++ + ++ ++ ++
Mesangial matrix hyperplasia + - + + - - + - +
Note: Ca. case, f focal
Table 1 Summary of the clinical and serological features of renal biopsies from 9 patients
Ca.1 Ca.2 Ca.3 Ca.4 Ca.5 Ca.6 Ca.7 Ca.8 Ca.9
Age 41 42 28 42 36 25 41 48 42
Sex F F M M M M F F M
Prodromal infection history Non Non Non Non Non Non Non Non Non
Family history of kidney diseases Non Non Non Non Non Non Non Non Non
Gross hematuria Non Non Non Non Non Non Non Non Non
Hypertension Non >10ys Non Non Non Non Non Non Non
Microscopic hematuria(/μL) 37 8.58 29 27 15.18 45 0 40 0
Proteinuria +++ ++ +++ +++ ++++ +++ ++ +++ +++
24TP(g/24 h) 2.97 1.79 2.28 7.61 11.76 2.59 2.4 6.42 5.52
Serum creatinine(μmol/L) 49 68 90 64 93 66 52 49 87
Serum ALB(g/L) 25.8 32.8 34.6 21.2 20.6 44.9 36.1 23.5 27.4
Serum IgA(g/L) 1.12 3.32 1.36 2.58 1.84 3.59 1.11 4.8 2.44
Serum C3(g/L) 0.87 1.45 0.93 1.34 1.05 1.08 0.95 1.32 1.01
Serum anti-PLA2R(RU/mL) 69.1 34.6 31.5 53.4 177.1 27 24.6 32.9 66.3
Serum autoantibodies - - - - - - - - -
Serum HBV markers - - - - - - - - -
ANCA - - - - - - - - -
Note: Ca. case, F female, M male
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Discussion and conclusion
We examined the clinical and morphological features
of samples collected from each of the 9 cases of idio-
pathic MN combined with IgAN. This complication of
GN was defined morphologically, with emphasis on the
presence of the PLA2R antibody in serum and PLA2R
expression in glomeruli, rather than on the basis of the
immunofluorescence assay and transmission electron
microscopy.
MN and IgAN are both glomerular diseases mediated
by immune complex deposition. The depositing site of
the immune complex is different in these two forms of
GN due to the diverse mechanisms associated with im-
mune complex formation. These mechanisms are influ-
enced by many factors such as the relative molecular
weight and the volume and charge of the immune com-
plex, which may be the cause of the different clinical
manifestations and pathological morphology of the two
renal diseases. It is found that idiopathic MN with IgAN
complications combine the clinical and pathological
manifestations of these two types of glomerular diseases.
Previous reports regarding patients presenting idiopathic
MN with IgAN show that the average age of the patients
was 40 years old. Furthermore, the patients in those
studies had proteinuria, of which 50 % exhibited heavy
proteinuria with nephrotic syndrome. 90 % of the pa-
tients examined in these reports presented microscopic
hematuria, and 30 % of these patients presented hyper-
tension [6–10]. In this group, the clinical and patho-
logical features of the 9 cases examined were similar to
that found in previous reports. These findings are con-
sistent with the clinical characteristics of MN and IgAN.
However, the differences noted in the previous reports
and the current study are that the age of renal disease
onset in the 9 cases is younger than that in the simple
idiopathic MN, and that the deposition of IgA EDD was
lesser compared to IgG EDD in patients of MN com-
bined with IgAN.
In the present study, the immunofluorescence stain-
ing showed granular positive IgG along the capillary
loop, while IgA was shown to be irregularly positive in
the mesangial area. Meanwhile, the EDD of the sube-
pithelial and mesangial area were found using electron
microscopy. The mixed immunoglobulins deposition
phenomenon is common in many secondary glomer-
ulonephritis, which may cause confusion for diagnosis
and differentiation. Wang et al. reported that use of the
colloidal gold-immune electron microscopy technique
displayed an IgG positive subepithelial deposition,
while the anti-IgA was positive in the mesangial depos-
ition, confirming the different location of IgG and IgA
in the complication [10].
Idiopathic MN is recognized as an autoimmune dis-
ease [17]. Recently, progress has been made in under-
standing the pathogens of idiopathic MN with the
finding of M-type PLA2R as the target antigen of podo-
cytes in patients with idiopathic MN [11, 12]. It has
been revealed that a majority of patients with idiopathic
MN were found to possess anti-PLA2R autoantibodies
in circulation, tissue PLA2R expression in their biopsy
kidney tissue, and that the level of autoantibody corre-
lates with the level of proteinuria [11, 18]. Moreover,
Beck et al. along with other investigators showed that
serum anti-PLA2R or tissue PLA2R is high detect abil-
ity in idiopathic MN, but both are rarely detected in
secondary MN [15]. Hoxha et al. found that a high ratio
of PLA2R positive in the stained glomeruli of patients
with idiopathic MN tightly correlates with the presence
of serum PLA2R autoantibodies, while this correlation
is lower in secondary MN with respect to PLA2R stain-
ing [16]. This method of detection may help discrimin-
ate between idiopathic MN from secondary MN. In the
9 cases presented herein, we observed increased serum
anti-PLA2R, and glomerular PLA2R positive immuno-
fluorescence staining, associated with IgG subepithelial
deposits,and immunofluorescence positive of mesangial
Fig. 1 Cases 1–4 immunofluorescence for immunoglobulins and
EDD detected by electron microscopy. Immunofluorescence in cases
1–4 for a IgG, b IgG4, c IgA, d PLA2R and e C3. f The EDD detected
by electron microscopy in case 1–4. White arrows, subepithelial
deposits; Inset: boxed mesangial deposits
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IgA and mesangial EDD deposition. Therefore, these
patients were confirmed as idiopathic MN combined
with IgAN. It is suggested that PLA2R determination is
an important assistant biomarker for the diagnosis of
idiopathic MN associated with IgAN.
Of note, the 9 cases of idiopathic MN combined with
IgAN presented herein had predominant IgG4 and
PLA2R co-localized within the subepithelial immune de-
posits. IgG subtype analysis has been suggested that
IgG4-predominant staining is mainly associated with
idiopathic MN, whereas IgG1, IgG2, and IgG3 predom-
inate in the deposits of secondary MN [11, 19–23]. Pre-
liminary studies suggest that there may be a direct
interaction of anti-PLA2R-IgG4 with the PLA2R mol-
ecule, and this interaction activates complement by
binding the Fc portion of IgG4 [24]. Furthermore, anti-
PLA2R-IgG4 has been described as a predominant circu-
lating IgG subclass in idiopathic MN. The presence of
these combined molecules seem to be specific (89 %) to
idiopathic MN [13, 25, 26] and can be utilized as sup-
portive data to exclude the presence of secondary MN
[13]. Herein, the analysis of the presented cases reveal
the significant implications for the diagnosis of idio-
pathic MN complicated with other renal diseases.
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